Spatiotemporal Phylodynamics of Hepatitis C Among People Who Inject Drugs in India
- PMID: 34008172
- PMCID: PMC8756458
- DOI: 10.1002/hep.31912
Spatiotemporal Phylodynamics of Hepatitis C Among People Who Inject Drugs in India
Abstract
Background and aims: Implementing effective interventions for HCV requires a detailed understanding of local transmission dynamics and geospatial spread. Little is known about HCV phylodynamics, particularly among high-burden populations, such as people who inject drugs (PWID).
Approach and results: We used 483 HCV sequences and detailed individual-level data from PWID across four Indian cities. Bayesian phylogeographic analyses were used to evaluate transmission hotspots and geospatial diffusion of the virus. Phylogenetic cluster analysis was performed to infer epidemiologic links and factors associated with clustering. A total of 492 HIV sequences were used to draw comparisons within the same population and, in the case of coinfections, evaluate molecular evidence for shared transmission pathways. Overall, 139/483 (28.8%) of HCV sequences clustered with a median cluster size of 3 individuals. Genetically linked participants with HCV were significantly younger and more likely to be infected with HCV subtype 3b as well as to live and inject close to one another. Phylogenetic evidence suggests likely ongoing HCV infection/reinfection with limited support for shared HIV/HCV transmission pathways. Phylogeographic analyses trace historic HCV spread back to Northeastern India and show diffusion patterns consistent with drug trafficking routes.
Conclusions: This study characterizes HCV phylodynamics among PWID in a low and middle-income country setting. Heterogeneity and recent genetic linkage of HCV across geographically disparate Indian states suggest that targeted interventions could help prevent reimportation of virus through drug trafficking routes.
© 2021 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.
Conflict of interest statement
Conflict of Interest Statement
SHM reports personal fees from Gilead Sciences, outside the submitted work. SSS reports grants/products and advisory board fees from Gilead Sciences and grants/products from Abbott Diagnostics, outside the submitted work.
Figures





Similar articles
-
Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: a cross-sectional community-based network analysis in New Delhi, India.Elife. 2021 Aug 3;10:e69174. doi: 10.7554/eLife.69174. Elife. 2021. PMID: 34342266 Free PMC article.
-
Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.PLoS Med. 2017 Nov 28;14(11):e1002460. doi: 10.1371/journal.pmed.1002460. eCollection 2017 Nov. PLoS Med. 2017. PMID: 29182638 Free PMC article.
-
Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore.BMC Infect Dis. 2020 Nov 10;20(1):815. doi: 10.1186/s12879-020-05546-x. BMC Infect Dis. 2020. PMID: 33167892 Free PMC article.
-
Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and meta-analysis.Arch Virol. 2020 Sep;165(9):1947-1958. doi: 10.1007/s00705-020-04716-1. Epub 2020 Jul 2. Arch Virol. 2020. PMID: 32617764
-
HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs.Curr HIV/AIDS Rep. 2017 Jun;14(3):110-121. doi: 10.1007/s11904-017-0358-8. Curr HIV/AIDS Rep. 2017. PMID: 28432579 Review.
Cited by
-
Widespread hepatitis C virus transmission network among people who inject drugs in Kenya.Int J Infect Dis. 2024 Oct;147:107215. doi: 10.1016/j.ijid.2024.107215. Epub 2024 Sep 7. Int J Infect Dis. 2024. PMID: 39182826 Free PMC article.
-
Leveraging insect-specific viruses to elucidate mosquito population structure and dynamics.PLoS Pathog. 2023 Aug 31;19(8):e1011588. doi: 10.1371/journal.ppat.1011588. eCollection 2023 Aug. PLoS Pathog. 2023. PMID: 37651317 Free PMC article. Review.
-
Network-based strategies to combat HCV: Examining social and spatial drivers of transmission among PWID in New Delhi.J Viral Hepat. 2024 Sep;31(9):535-543. doi: 10.1111/jvh.13960. Epub 2024 Jun 4. J Viral Hepat. 2024. PMID: 38837275
-
Plasma Virome Reveals Blooms and Transmission of Anellovirus in Intravenous Drug Users with HIV-1, HCV, and/or HBV Infections.Microbiol Spectr. 2022 Aug 31;10(4):e0144722. doi: 10.1128/spectrum.01447-22. Epub 2022 Jun 27. Microbiol Spectr. 2022. PMID: 35758682 Free PMC article.
-
Spatiotemporal heterogeneity and impact factors of hepatitis B and C in China from 2010 to 2018: Bayesian space-time hierarchy model.Front Cell Infect Microbiol. 2023 Feb 27;13:1115087. doi: 10.3389/fcimb.2023.1115087. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 36923590 Free PMC article.
References
-
- Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 2007;18:352–358. - PubMed
-
- Joint United Nations Programme on HIV/AIDS. Do No Harm—Health, Human Rights, and People Who Use Drugs. Geneva, Switzerland: UNAIDS; 2016.
-
- Sulkowski MS, Gardiner DF, Rodriguez-Torres M, Reddy KR, Hassanein T, Jacobson I, Lawitz E, et al. Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. N Engl J Med 2014;370:211–221. - PubMed
-
- Afdhal N, Zeuzem S, Kwo P, Chojkier M, Gitlin N, Puoti M, Romero-Gomez M, et al. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N Engl J Med 2014;370:1889–1898. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical